NASDAQ:VIR

Vir Biotechnology - VIR News Today

$30.85

+0.86 (+2.87%)

(As of 01/27/2023 12:00 AM ET)

Add

Compare

Today's Range: $29.91
▼
$31.55
50-Day Range: $24.80
▼
$30.85
52-Week Range: $18.05
▼
$35.48

Volume: 767,934 shs
Average Volume: 697,478 shs
Market Capitalization: $4.11 billion

P/E Ratio: 3.63
Dividend Yield: N/A
Price Target: $52.50

Institutional Ownership

Get Vir Biotechnology News Delivered to You Automatically

VIR Media Mentions By Week

VIR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VIR
News Sentiment
▼
0.41

0.71
▲
Average
Medical
News Sentiment

VIR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VIR Articles
This Week
▼
25

4
▲
VIR Articles
Average Week

Source

Source	Headline
	Royce & Associates LP Invests $546,000 in Vir Biotechnology, Inc. (NASDAQ:VIR) marketbeat.com - January 27 at 5:35 AM
	Bank Julius Baer & Co. Ltd Zurich Sells 65,007 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) marketbeat.com - January 26 at 7:14 AM
	Comerica Bank Sells 5,405 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) marketbeat.com - January 24 at 4:29 AM
	Los Angeles Capital Management LLC Boosts Stock Position in Vir Biotechnology, Inc. (NASDAQ:VIR) marketbeat.com - January 23 at 5:52 AM
	Vir Biotechnology (NASDAQ:VIR) Upgraded to "Equal Weight" at Morgan Stanley americanbankingnews.com - January 28 at 6:28 AM
	Vir Biotechnology (NASDAQ:VIR) Price Target Cut to $43.00 by Analysts at SVB Leerink americanbankingnews.com - January 28 at 6:28 AM
	Endurance (Cayman) Ltd Svf Sells 36,512 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock americanbankingnews.com - January 28 at 5:10 AM
	Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Insider Sells 30,000 Shares of Stock americanbankingnews.com - January 28 at 5:10 AM
	SVB Securities Keeps Their Buy Rating on Vir Biotechnology (VIR) markets.businessinsider.com - January 27 at 8:16 AM
	Analyst Expectations for Vir Biotechnology's Future markets.businessinsider.com - January 27 at 8:16 AM
	'You have to have the goods': Retiring Vir CEO George Scangos looks back on building great companies bizjournals.com - January 26 at 9:20 AM
	'You have to have the goods': Retiring Vir CEO George Scangos on building great companies finance.yahoo.com - January 25 at 6:52 PM
	Wednesday Digest: S.F. sets a massive housing goal; Biotech names a new CEO bizjournals.com - January 25 at 1:23 PM
	Covid Drugmaker Vir Replaces CEO With Bayer Executive as It Searches for Next Hit bloomberg.com - January 25 at 1:23 PM
	Vir Biotechnology Announces Retirement of CEO George Scangos, Ph.D.; Appoints Marianne De Backer, MSc, Ph.D., MBA, as Successor finance.yahoo.com - January 25 at 8:51 AM
	Endurance (Cayman) Ltd Svf Sells 69,839 Shares of Vir Biotechnology, Inc. (NASDAQ:VIR) Stock americanbankingnews.com - January 25 at 4:32 AM
	Vir Biotechnology, Inc. (VIR) Moves to Strong Buy: Rationale Behind the Upgrade finance.yahoo.com - January 24 at 2:39 PM
	2 Stocks That Could Turn $100 Into $1,000 by 2028 msn.com - January 22 at 8:07 AM
	10 Best Healthcare Stocks For the Long Term finance.yahoo.com - January 21 at 6:11 PM
	Are Robust Financials Driving The Recent Rally In Vir Biotechnology, Inc.'s (NASDAQ:VIR) Stock? finance.yahoo.com - January 21 at 8:10 AM
	Is Vir Biotechnology (VIR) Outperforming Other Medical Stocks This Year? finance.yahoo.com - January 20 at 1:48 PM
	Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 88,372 Shares of Stock americanbankingnews.com - January 20 at 6:16 AM
	Vir Biotechnology: High Potential Returns With High Volatility Risks seekingalpha.com - January 19 at 7:47 AM
	Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 94,199 Shares americanbankingnews.com - January 19 at 4:12 AM
	Former CEO says Biogen 'shot themselves in the foot' by deciding to charge $56,000 for its controversial Alzheimer's drug businessinsider.com - January 18 at 8:37 AM
	Analysts Set Vir Biotechnology, Inc. (NASDAQ:VIR) Price Target at $52.50 americanbankingnews.com - January 18 at 4:02 AM
	Vir Biotechnology to Highlight Anticipated 2023 Catalysts and Long-Term Growth Strategy at 41st Annual J.P. Morgan Healthcare Conference finance.yahoo.com - January 3 at 4:59 PM
	Are Investors Undervaluing Vir Biotechnology, Inc. (NASDAQ:VIR) By 32%? finance.yahoo.com - December 31 at 12:13 PM
	Drug companies set sights on new COVID medicines to boost depleted arsenal msn.com - December 27 at 8:26 PM
	Drug companies set sights on new COVID medicines to boost depleted arsenal msn.com - December 27 at 8:26 PM
	Vir Biotechnology: A 'Magic Formula' Top Performer finance.yahoo.com - December 22 at 6:12 PM
	Vir Biotechnology Achieves Target Enrollment for Groundbreaking Phase 2 PENINSULA Trial Evaluating VIR-2482 for Prevention of Seasonal Influenza A finance.yahoo.com - December 21 at 9:18 AM
	Vir Biotechnology: Collaborative Approach To Taking On Serious Diseases seekingalpha.com - December 17 at 10:22 AM
	With 49% stake, Vir Biotechnology, Inc. (NASDAQ:VIR) seems to have captured institutional investors' interest finance.yahoo.com - December 6 at 8:54 AM
	2 Fast-Growing Healthcare Stocks to Buy and Hold finance.yahoo.com - December 2 at 9:12 AM
	BioNTech, Vertex Pharmaceuticals And Other Big Biotechnology Stocks From Benzinga's Most Accurate Analysts markets.businessinsider.com - December 2 at 7:08 AM
	Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 71%: Here's is How to Trade finance.yahoo.com - November 24 at 2:13 PM
	Should Value Investors Buy Vir Biotechnology (VIR) Stock? finance.yahoo.com - November 22 at 4:30 PM
	After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade msn.com - November 18 at 4:44 PM
	99 Bay Area companies named in Deloitte 'fast 500' list, including its No. 1 bizjournals.com - November 18 at 9:11 AM
	99 Bay Area companies named in Deloitte's Technology Fast 500 list, including its No. 1 finance.yahoo.com - November 18 at 9:11 AM
	Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™ finance.yahoo.com - November 16 at 4:06 PM
	Vir Biotechnology Ranked the Fastest-Growing Company in North America on the 2022 Deloitte Technology Fast 500™ finance.yahoo.com - November 16 at 4:06 PM
	Moore Kuehn, PLLC Encourages Investors of Vir Biotechnology, Inc. to Contact Law Firm benzinga.com - November 10 at 5:23 PM
	Vir Biotechnology Third Quarter 2022 Earnings: Beats Expectations finance.yahoo.com - November 9 at 10:33 AM
	Wall Street Analysts Predict a 107% Upside in Vir Biotechnology, Inc. (VIR): Here's What You Should Know finance.yahoo.com - November 8 at 2:59 PM
	Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday msn.com - November 7 at 4:46 AM
	Vir Biotechnology Presents New Data Evaluating the Potential for VIR-2218 and VIR-3434 to Achieve a Functional Cure for Chronic Hepatitis B Virus (HBV) Infection finance.yahoo.com - November 6 at 5:18 PM
	Analyst Forecasts For Vir Biotechnology, Inc. (NASDAQ:VIR) Are Surging Higher finance.yahoo.com - November 5 at 1:41 PM
	Top Biotech Stocks for Q4 2022 finance.yahoo.com - November 4 at 7:04 PM
	Why Vir Biotechnology Jumped Nearly 19% Today finance.yahoo.com - November 4 at 4:48 PM
	Needham Reaffirms Their Buy Rating on Vir Biotechnology (VIR) markets.businessinsider.com - November 4 at 2:02 PM
	What 5 Analyst Ratings Have To Say About Vir Biotechnology markets.businessinsider.com - November 4 at 2:02 PM
	Vir Biotechnology, Inc. (VIR) Q3 Earnings and Revenues Surpass Estimates finance.yahoo.com - November 4 at 2:02 PM

Get Vir Biotechnology News Delivered to You Automatically

This page (NASDAQ:VIR) was last updated on 1/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Vir Biotechnology - VIR News Today

VIR Media Mentions By Week

VIR Media Sentiment

VIR News Coverage

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info